NO20030461D0 - Analysemetode for plateaktiveringsfaktor - Google Patents

Analysemetode for plateaktiveringsfaktor

Info

Publication number
NO20030461D0
NO20030461D0 NO20030461A NO20030461A NO20030461D0 NO 20030461 D0 NO20030461 D0 NO 20030461D0 NO 20030461 A NO20030461 A NO 20030461A NO 20030461 A NO20030461 A NO 20030461A NO 20030461 D0 NO20030461 D0 NO 20030461D0
Authority
NO
Norway
Prior art keywords
paf
analysis method
factor analysis
mass spectrometry
activation factor
Prior art date
Application number
NO20030461A
Other languages
English (en)
Inventor
Yasushi Kanai
Yujiro Hayashi
Norio Onuma
Hiroshi Miyazaki
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of NO20030461D0 publication Critical patent/NO20030461D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
NO20030461A 2001-05-31 2003-01-29 Analysemetode for plateaktiveringsfaktor NO20030461D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001164982 2001-05-31
PCT/JP2002/005369 WO2002097435A2 (en) 2001-05-31 2002-05-31 Assay method for platelet-activating factor

Publications (1)

Publication Number Publication Date
NO20030461D0 true NO20030461D0 (no) 2003-01-29

Family

ID=19007715

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030461A NO20030461D0 (no) 2001-05-31 2003-01-29 Analysemetode for plateaktiveringsfaktor

Country Status (10)

Country Link
US (1) US20040175776A1 (no)
EP (1) EP1390759B1 (no)
JP (1) JP4087334B2 (no)
AT (1) ATE291740T1 (no)
AU (1) AU2002302977A1 (no)
BR (1) BR0205443A (no)
DE (1) DE60203388T2 (no)
ES (1) ES2239230T3 (no)
NO (1) NO20030461D0 (no)
WO (1) WO2002097435A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009012595A1 (en) * 2007-07-26 2009-01-29 Phenomenome Discoveries Inc. Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders
JP5351076B2 (ja) * 2010-02-26 2013-11-27 杏林製薬株式会社 オンライン固相抽出による生体試料液中薬剤成分の定量方法
JP5982676B2 (ja) * 2011-02-28 2016-08-31 学校法人 いわき明星大学 抗ｐａｆ活性を有するビオチニル化ペプチド化合物
CN107624161A (zh) 2015-03-02 2018-01-23 科罗纳里康赛普茨有限责任公司 用于peg代谢物及peg分解产物检测的化合物及方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78246B (no) * 1981-01-23 1984-09-26 Ciba Geigy Ag
DE3445950A1 (de) * 1984-12-17 1986-06-19 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur isolierung von lysophosphatidylcholin-freiem phosphatidylcholin aus ei-pulver
FR2630006B1 (fr) * 1988-04-18 1991-07-19 Pasteur Institut Nouvelle preparation de recepteurs du paf et nouvelle methode de dosage du paf

Also Published As

Publication number Publication date
ES2239230T3 (es) 2005-09-16
DE60203388T2 (de) 2006-04-13
EP1390759B1 (en) 2005-03-23
EP1390759A2 (en) 2004-02-25
WO2002097435A3 (en) 2003-09-04
DE60203388D1 (de) 2005-04-28
WO2002097435A2 (en) 2002-12-05
JP2004527770A (ja) 2004-09-09
AU2002302977A1 (en) 2002-12-09
JP4087334B2 (ja) 2008-05-21
BR0205443A (pt) 2003-07-08
US20040175776A1 (en) 2004-09-09
ATE291740T1 (de) 2005-04-15

Similar Documents

Publication Publication Date Title
Musselman et al. Binding of the CHD4 PHD2 finger to histone H3 is modulated by covalent modifications
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
DE60239968D1 (de) Sche
AU2003243558A8 (en) Test strip for detection of analyte and methods of use
DE60231974D1 (de) Inline-testeinrichtung und verfahren zur verwendung
ATE307903T1 (de) Immunologischer nachweis von rna:dna hybriden auf mikroarrays
MX340856B (es) Sistema y metodos que determinan concentracion de analito utilizando amperometria resuelta en tiempo.
DE602006011756D1 (de) Komplexformierungs- und -trennungsverfahren
DE50210025D1 (de) Schnelltest für biologische substanzen mittels ftir
Kruse et al. Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid
DE602005014386D1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
DK1311707T3 (da) Massespektroskopisk analyse af biopolymerer
DE602005022709D1 (de) Quantifizierungsverfahren für die vegf isoformen einer biologischen probe
JP2020514689A5 (no)
DE69633468D1 (de) Spektroskopische messungen an lichtstreuendem prüfgut mittels integrations -hohlraum
WO2004042403A3 (en) Methods, device and instrument for detection of analytes
BR9908059A (pt) Método de análise para espécies especìficas de conformações de uma proteìna relacionadas a várias doenças
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
NO20030461D0 (no) Analysemetode for plateaktiveringsfaktor
WO2002010456A3 (en) Multiparameter analysis for predictive medicine
Moitra et al. Metabolomics of respiratory diseases
HK1091540A1 (en) Use of a virus expressing a binding moiety to measure analytes in a sample
Yin et al. A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC50 determination
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
FR2384261A1 (fr) Composition a base d'un hydroperoxyde, dispositif et methode pour le dosage de substances a action de peroxydase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application